HomeVRDN • NASDAQ
add
Viridian Therapeutics Inc
Previous close
$19.65
Day range
$18.86 - $19.57
Year range
$9.90 - $27.20
Market cap
1.54B USD
Avg Volume
876.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 75.00K | 4.17% |
Operating expense | 20.22M | 25.83% |
Net income | -100.74M | -54.99% |
Net profit margin | -134.31K | -48.79% |
Earnings per share | -1.00 | 1.96% |
EBITDA | -106.65M | -48.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 563.36M | -1.40% |
Total assets | 582.32M | -0.57% |
Total liabilities | 67.16M | 19.23% |
Total equity | 515.17M | — |
Shares outstanding | 81.66M | — |
Price to book | 4.91 | — |
Return on assets | -42.94% | — |
Return on capital | -45.79% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -100.74M | -54.99% |
Cash from operations | -75.37M | -63.65% |
Cash from investing | 75.72M | 22.17% |
Cash from financing | 764.00K | 607.41% |
Net change in cash | 1.11M | -93.08% |
Free cash flow | -40.52M | -80.44% |
About
Founded
2010
Headquarters
Website
Employees
143
